Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-020033
Filing Date
2023-01-31
Accepted
2023-01-31 13:03:01
Documents
7
Period of Report
2023-01-31

Document Format Files

Seq Description Document Type Size
1 6-K d458736d6k.htm 6-K 11116
2 EX-99.1 d458736dex991.htm EX-99.1 29842
3 EX-99.2 d458736dex992.htm EX-99.2 29482
4 EX-99.3 d458736dex993.htm EX-99.3 39070
5 GRAPHIC g458736dsp.jpg GRAPHIC 3278
6 GRAPHIC g458736dspa.jpg GRAPHIC 1501
7 GRAPHIC g458736g0131023910167.jpg GRAPHIC 2601
  Complete submission text file 0001193125-23-020033.txt   121273
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 23571410
SIC: 2834 Pharmaceutical Preparations